Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
12.21
+0.38 (3.21%)
Apr 28, 2025, 4:00 PM EDT - Market closed

Cartesian Therapeutics Revenue

In the year 2024, Cartesian Therapeutics had annual revenue of $38.91M with 49.64% growth. Cartesian Therapeutics had revenue of $-759.00K in the quarter ending December 31, 2024, a decrease of -109.18%.

Revenue (ttm)
$38.91M
Revenue Growth
+49.64%
P/S Ratio
5.42
Revenue / Employee
$589,591
Employees
66
Market Cap
316.33M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202438.91M12.91M49.64%
Dec 31, 202326.00M-84.77M-76.53%
Dec 31, 2022110.78M25.70M30.21%
Dec 31, 202185.08M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.